Picard Medical, Inc. (PMI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
2/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LosePMI / S&P -84.23% / 15.20% |
WinPMI / S&P 41.00% / 15.00% |
LosePMI / S&P PMI unavailable / 50.40% |
| 2026-Q11/3 |
LosePMI / S&P -40.57% / -4.33% |
WinPMI / S&P 80.70% / 11.30% |
LosePMI / S&P PMI unavailable / 27.70% |
| 2025-Q40/3 |
LosePMI / S&P -79.41% / 2.65% |
LosePMI / S&P PMI unavailable / 9.00% |
LosePMI / S&P PMI unavailable / 13.40% |
| 2025-Q30/3 |
LosePMI / S&P PMI unavailable / 8.12% |
LosePMI / S&P PMI unavailable / 4.61% |
LosePMI / S&P PMI unavailable / 13.45% |
| 2025-Q20/3 |
LosePMI / S&P PMI unavailable / 10.94% |
LosePMI / S&P PMI unavailable / 4.83% |
LosePMI / S&P PMI unavailable / 10.63% |
| 2025-Q10/3 |
LosePMI / S&P PMI unavailable / -4.27% |
LosePMI / S&P PMI unavailable / 4.98% |
LosePMI / S&P PMI unavailable / 10.57% |
| 2024-Q40/3 |
LosePMI / S&P PMI unavailable / 2.41% |
LosePMI / S&P PMI unavailable / 5.25% |
LosePMI / S&P PMI unavailable / 6.15% |
| 2024-Q30/3 |
LosePMI / S&P PMI unavailable / 5.89% |
LosePMI / S&P PMI unavailable / 5.89% |
LosePMI / S&P PMI unavailable / 6.11% |
| 2024-Q20/3 |
LosePMI / S&P PMI unavailable / 4.28% |
LosePMI / S&P PMI unavailable / 5.38% |
LosePMI / S&P PMI unavailable / 5.12% |
| 2024-Q10/3 |
LosePMI / S&P PMI unavailable / 10.56% |
LosePMI / S&P PMI unavailable / 5.71% |
LosePMI / S&P PMI unavailable / 5.59% |
| 2023-Q40/3 |
LosePMI / S&P PMI unavailable / 11.69% |
LosePMI / S&P PMI unavailable / 6.81% |
LosePMI / S&P PMI unavailable / 7.78% |
| 2023-Q30/3 |
LosePMI / S&P PMI unavailable / -3.27% |
LosePMI / S&P PMI unavailable / 7.52% |
LosePMI / S&P PMI unavailable / -5.03% |
| 2023-Q20/3 |
LosePMI / S&P PMI unavailable / 8.74% |
LosePMI / S&P PMI unavailable / 9.50% |
LosePMI / S&P PMI unavailable / -8.57% |
| 2023-Q10/3 |
LosePMI / S&P PMI unavailable / 7.50% |
LosePMI / S&P PMI unavailable / 10.77% |
LosePMI / S&P PMI unavailable / -15.69% |
| 2022-Q40/3 |
LosePMI / S&P PMI unavailable / 7.56% |
LosePMI / S&P PMI unavailable / 11.88% |
LosePMI / S&P PMI unavailable / -17.99% |
| 2022-Q30/3 |
LosePMI / S&P PMI unavailable / -4.88% |
LosePMI / S&P PMI unavailable / 13.47% |
LosePMI / S&P PMI unavailable / -1.41% |
| 2022-Q20/3 |
LosePMI / S&P PMI unavailable / -16.10% |
LosePMI / S&P PMI unavailable / 13.71% |
LosePMI / S&P PMI unavailable / 11.04% |
| 2022-Q10/3 |
LosePMI / S&P PMI unavailable / -4.60% |
LosePMI / S&P PMI unavailable / 15.97% |
LosePMI / S&P PMI unavailable / 42.23% |
| 2021-Q40/3 |
LosePMI / S&P PMI unavailable / 11.03% |
LosePMI / S&P PMI unavailable / 15.00% |
LosePMI / S&P PMI unavailable / 96.40% |
| 2021-Q30/3 |
LosePMI / S&P PMI unavailable / 0.58% |
LosePMI / S&P PMI unavailable / 10.77% |
LosePMI / S&P PMI unavailable / 69.42% |
| 2021-Q20/3 |
LosePMI / S&P PMI unavailable / 8.55% |
LosePMI / S&P PMI unavailable / 6.58% |
LosePMI / S&P PMI unavailable / 51.81% |
| 2021-Q10/3 |
LosePMI / S&P PMI unavailable / 6.17% |
LosePMI / S&P PMI unavailable / -1.06% |
LosePMI / S&P PMI unavailable / 7.39% |
| 2020-Q40/3 |
LosePMI / S&P PMI unavailable / 12.15% |
LosePMI / S&P PMI unavailable / -3.72% |
LosePMI / S&P PMI unavailable / -33.42% |
| 2020-Q30/3 |
LosePMI / S&P PMI unavailable / 8.93% |
LosePMI / S&P PMI unavailable / -2.04% |
LosePMI / S&P PMI unavailable / -27.10% |
| 2020-Q20/3 |
LosePMI / S&P PMI unavailable / 20.54% |
LosePMI / S&P PMI unavailable / -0.46% |
LosePMI / S&P PMI unavailable / -27.11% |
| 2020-Q10/3 |
LosePMI / S&P PMI unavailable / -19.60% |
LosePMI / S&P PMI unavailable / 3.47% |
LosePMI / S&P PMI unavailable / -14.75% |
| 2019-Q40/3 |
LosePMI / S&P PMI unavailable / 9.07% |
LosePMI / S&P PMI unavailable / 5.36% |
LosePMI / S&P PMI unavailable / 2.99% |
| 2019-Q30/3 |
LosePMI / S&P PMI unavailable / 1.70% |
LosePMI / S&P PMI unavailable / 5.02% |
LosePMI / S&P PMI unavailable / 0.21% |
| 2019-Q20/3 |
LosePMI / S&P PMI unavailable / 4.30% |
LosePMI / S&P PMI unavailable / 6.64% |
LosePMI / S&P PMI unavailable / 8.65% |
| 2019-Q10/3 |
LosePMI / S&P PMI unavailable / 13.65% |
LosePMI / S&P PMI unavailable / 8.12% |
LosePMI / S&P PMI unavailable / 14.29% |
| 2018-Q40/3 |
LosePMI / S&P PMI unavailable / -13.52% |
LosePMI / S&P PMI unavailable / 9.05% |
LosePMI / S&P PMI unavailable / 18.23% |
| 2018-Q30/3 |
LosePMI / S&P PMI unavailable / 7.71% |
LosePMI / S&P PMI unavailable / 10.21% |
LosePMI / S&P PMI unavailable / 19.06% |
| 2018-Q20/3 |
LosePMI / S&P PMI unavailable / 3.43% |
LosePMI / S&P PMI unavailable / 9.03% |
LosePMI / S&P PMI unavailable / 14.46% |
| 2018-Q10/3 |
LosePMI / S&P PMI unavailable / -0.76% |
LosePMI / S&P PMI unavailable / 7.68% |
LosePMI / S&P PMI unavailable / 12.46% |
| 2017-Q40/3 |
LosePMI / S&P PMI unavailable / 6.64% |
LosePMI / S&P PMI unavailable / 7.03% |
LosePMI / S&P PMI unavailable / 13.82% |
| 2017-Q30/3 |
LosePMI / S&P PMI unavailable / 4.48% |
LosePMI / S&P PMI unavailable / 5.68% |
LosePMI / S&P PMI unavailable / 17.57% |
| 2017-Q20/3 |
LosePMI / S&P PMI unavailable / 3.09% |
LosePMI / S&P PMI unavailable / 4.83% |
LosePMI / S&P PMI unavailable / 17.74% |
| 2017-Q10/3 |
LosePMI / S&P PMI unavailable / 6.07% |
LosePMI / S&P PMI unavailable / 3.67% |
LosePMI / S&P PMI unavailable / 13.32% |
| 2016-Q40/3 |
LosePMI / S&P PMI unavailable / 3.82% |
LosePMI / S&P PMI unavailable / 2.09% |
LosePMI / S&P PMI unavailable / 7.05% |
| 2016-Q30/3 |
LosePMI / S&P PMI unavailable / 3.85% |
LosePMI / S&P PMI unavailable / 0.20% |
LosePMI / S&P PMI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PMI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.04% | 20.78% |
| Annualized return | -96.04% | 20.78% |
5Y · 2025-08-29 to 2026-08-27
| Metric | PMI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.04% | 83.14% |
| Annualized return | -47.57% | 12.86% |
10Y · 2025-08-29 to 2026-08-27
| Metric | PMI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.04% | 319.30% |
| Annualized return | -27.59% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |